Background: Vitamin D has garnered much attention for its role in immune function, more specifically, it’s conceivable link to the clinical severity of Covid-19 infections and therefore its potential application in prophylactic or therapeutic treatment. Vitamin D appears capable of inhibiting pulmonary inflammatory responses while enhancing innate defence mechanisms against respiratory pathogens with population-based studies showing an association between circulating vitamin D levels and lung function. We understand that infection with Sars-Cov-2 induces production of pro and anti-inflammatory cytokines, whilst Vitamin D downregulates production of pro-inflammatory Th1 cytokines including tumour necrosis factor and interferon Y, whilst increasing expression of anti-inflammatory cytokines by macrophages. Vitamin D is also involved in the renin-angiotensin system which is regulated by entry of the SARS-Cov-2 virus into cells via the ACE2 receptor, leading to cytokine storms, with subsequent fatal respiratory distress syndrome. The theoretical implications for Vitamin D status in the presentation of Covid-19 (the disease state of Sars-Cov-2) exist, yet data on its application is currently limited. Geographical variables depicting patterns between sun exposure, diet or Vit D status, and risk of death from Covid-19 have shown strong negative correlation. Aim: We aim to assess levels of Vitamin D deficiency in ICU patients who have tested positive for Sars-Cov-2 and who have exhibited respiratory symptoms. In this way, we hope to identify the possibility of Vitamin D as a significant contributing factor to disease progression in Covid patients. Sample: Male or Female patients of any age, who were admitted to the Intensive Care Unit exhibiting respiratory symptoms, with a positive Sars-Cov-2 PCR test, between 12/3/21 and 25/2/21. sample total: 79. Results: Testing was very inconsistent with only 67.1% having their Vitamin D levels checked. There was average delay in testing levels by 2 days. 64% of patients were found to be very deficient. Conclusion: This study highlights the strong correlation between Vitamin D status and severity of Covid-19 disease and thus demonstrates a potential huge shortfall in the testing and treatment of this immunodeficiency as it relates to Covid-19. Based on recommendations of Vitamin D levels required for protection of this viral syndrome, as much as 100% of patients sampled with severe disease could be deficient in Vitamin D.
References
[1]
Dusso, A.S., Brown, A.J. and Slatopolsky, E. (2005) Vitamin D. American Journal of Physiology-Renal Physiology, 289, F8-F28.
https://doi.org/10.1152/ajprenal.00336.2004
[2]
Rondanelli, M., Miccono, A., Lamburghini, S., et al. (2018) Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds—Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds. Evidence-Based Complementary and Alternative Medicine, 2018, Article ID: 583095. https://doi.org/10.1155/2018/5813095
[3]
Aranow, C. (2011) Vitamin D and the Immune System. Journal of Investigative Medicine, 59, 881-886. https://doi.org/10.2310/JIM.0b013e31821b8755
[4]
Hughes, D.A. and Norton, R. (2009) Vitamin D and Respiratory Health. Clinical and Experimental Immunology, 158, 20-25.
https://doi.org/10.1111/j.1365-2249.2009.04001.x
[5]
Martineau, A.R., et al. (2017) Vitamin D Supplementation to Prevent Acute Respiratory Tract Infections: Systematic Review and Meta-Analysis of Individual Participant Data. BMJ, 356, Article No. i6583.
[6]
Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet, 395, 497-506.
https://doi.org/10.1016/S0140-6736(20)30183-5
[7]
Sharifi, A., Vahedi, H., Nedjat, S., Rafiei, H. and Hosseinzadeh-Attar, M.J. (2019) Effect of Single-Dose Injection of Vitamin D on Immune Cytokines in Ulcerative Colitis Patients: A Randomized Placebo-Controlled Trial. APMIS, 127, 681-687.
https://doi.org/10.1111/apm.12982
[8]
Rossi, G.A., Fanous, H. and Colin, A.A. (2020) Viral Strategies Predisposing to Respiratory Bacterial Superinfections. Pediatric Pulmonology, 55, 1061-1073.
https://doi.org/10.1002/ppul.24699
[9]
Ajabshir, S., Asif, A. and Nayer, A. (2014) The Effects of Vitamin D on the Renin-Angiotensin System. Journal of Nephropathology, 3, 41-43.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999581/
[10]
Dijkman, R., Jebbink, F., Deijs, M., Milewska, A., Pyrc, K., et al. (2012). Replication-Dependent Downregulation of Cellular Angiotensin-Converting Enzyme 2 Protein Expression by Human Coronavirus NL63. Journal of General Virology, 93, 1924-1929.
https://doi.org/10.1099/vir.0.043919-0
[11]
Ilie, P.C., Stefanescu, S. and Smith, L. (2020) The Role of Vitamin D in the Prevention of Coronavirus Disease 2019 Infection and Mortality. Aging Clinical and Experimental Research, 32, 1195-1198
https://link.springer.com/content/pdf/10.1007/s40520-020-01570-8.pdf
https://doi.org/10.1007/s40520-020-01570-8
[12]
Rhodes, J.M., Subramanian, S., Laird, E. and Kenny, R.A. (2020) Letter: Low Population Mortality from COVID-19 in Countries South of Latitude 35° North Supports Vitamin D as a Factor Determining Severity. Authors’ Reply. Alimentary Pharmacology & Therapeutics, 52, 412-413. https://doi.org/10.1111/apt.15823
[13]
Cannell, J.J., Vieth, R., Umhau, J.C., et al. (2006) Epidemic Influenza and Vitamin D. Epidemiology & Infection, 134, 1129-1140.
https://doi.org/10.1017/S0950268806007175
[14]
Patel, J.V., Chackathayil, J., Hughes, E.A., Webster, C., Lip, G.Y. and Gill, P.S. (2013) Vitamin D Deficiency amongst Minority Ethnic Groups in the UK: A Cross Sectional Study. International Journal of Cardiology, 167, 2172-2176.
https://doi.org/10.1016/j.ijcard.2012.05.081
[15]
Khunti, K., Singh, A.K., Pareek, M. and Hanif, W. (2020) Is Ethnicity Linked to Incidence or Outcomes of COVID-19? BMJ, 369, Article No. m1548.
https://doi.org/10.1136/bmj.m1548
[16]
Putzu, A., Belletti, A., Cassina, T., et al. (2017) Vitamin D and Outcomes in Adult Critically Ill Patients. A Systematic Review and Meta-Analysis of Randomized Trials. Journal of Critical Care, 38, 109-114.
https://doi.org/10.1016/j.jcrc.2016.10.029
[17]
Ginde, A.A., Brower, R.G., Caterino, J.M., et al. (2019) Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients. New England Journal of Medicine, 381, 2529-2540. https://doi.org/10.1056/NEJMoa1911124
[18]
Zhang, Y., Leung, D.Y. and Goleva, E. (2014) Anti-Inflammatory and Corticosteroid-Enhancing Actions of Vitamin D in Monocytes of Patients with Steroid-Resistant and Those with Steroid-Sensitive Asthma. Journal of Allergy and Clinical Immunology, 133, 1744-1752. https://doi.org/10.1016/j.jaci.2013.12.004
[19]
Mahboub, B., Al Heialy, S., Hachim, M.Y., Ramakrishnan, R.K., Alzaabi, A., Seliem, R.M., Salameh, L.I., Toor, S.M., Shendi, F.S., Al Ali, O.M., Safarini, B.K., Erabia, W.T., Halwani, R. and Hamid, Q. (2021) Vitamin D Regulates the Expression of Glucocorticoid Receptors in Blood of Severe Asthmatic Patients. Journal of Immunology Research, 2021, Article ID: 9947370.
https://doi.org/10.1155/2021/9947370
[20]
Ehrchen, J.M., Roth, J. and Barczyk-Kahlert, K. (2019) More than Suppression: Glucocorticoid Action on Monocytes and Macrophages. Frontiers in Immunology, 10, Article 2028. https://doi.org/10.3389/fimmu.2019.02028
[21]
Calton, E.K., Keane, K.N., Newsholme, P. and Soares, M.J. (2015) The Impact of Vitamin D Levels on Inflammatory Status: A Systematic Review of Immune Cell Studies. PLOS ONE, 10, e0141770. https://doi.org/10.1371/journal.pone.0141770
[22]
Castillo, M.E., Entrenas Costa, L.M., Vaquero Barrios, J.M., et al. (2020) Effect of Calcifediol Treatment and Best Available Therapy versus Best Available Therapy on Intensive Care Unit Admission and Mortality among Patients Hospitalized for COVID-19: A Pilot Randomized Clinical Study. The Journal of Steroid Biochemistry and Molecular Biology, 203, Article ID: 105751.
https://doi.org/10.1016/j.jsbmb.2020.105751
[23]
Kaufman, H.W., Niles, J.K., Kroll, M.H., Bi, C. and Holick, M.F. (2020) SARS-CoV-2 Positivity Rates Associated with Circulating 25-Hydroxyvitamin D Levels. PLOS ONE, 15, e0239252. https://doi.org/10.1371/journal.pone.0239252
[24]
Maghbooli, Z., Sahraian, M.A., Ebrahimi, M., Pazoki, M., Kafan, S., Tabriz, H.M., et al. (2020) Vitamin D Sufficiency, a Serum 25-Hydroxyvitamin D at Least 30 ng/mL Reduced Risk for Adverse Clinical Outcomes in Patients with COVID-19 Infection. PLOS ONE, 15, e0239799. https://doi.org/10.1371/journal.pone.0239799
[25]
Venkatesh, B. and Nair, P. (2014) Hypovitaminosis D and Morbidity in Critical Illness: Is There Proof beyond Reasonable Doubt? Critical Care, 18, Article No. 138.
https://doi.org/10.1186/cc13863
[26]
Lee, P., Eisman, J.A. and Center, J.R. (2009) Vitamin D Deficiency in Critically Ill Patients. New England Journal of Medicine, 350, 1912-1914.
https://doi.org/10.1056/NEJMc0809996
[27]
UK Scientific Advisory Committee on Nutrition (SACN) (2016) Vitamin D and Health. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/537616/SACN_Vitamin_D_and_Health_report.pdf
[28]
Martineau, A.R., Jolliffe, D.A., Hooper, R.L., et al. (2017) Vitamin D Supplementation to Prevent Acute Respiratory Tract Infections: Systematic Review and Meta-Analysis of Individual Participant Data. BMJ, 356, Article No. i6583.
https://doi.org/10.1136/bmj.i6583
[29]
Kimball, S.M., Mirhosseini, N. and Holick, M.F. (2017) Evaluation of Vitamin D3 Intakes Up to 15,000 International Units/Day and Serum 25-Hydroxyvitamin D Concentrations Up to 300 nmol/L on Calcium Metabolism in a Community Setting. Dermato-Endocrinology, 9, e1300213.
https://doi.org/10.1080/19381980.2017.1300213
[30]
Bergman, P. (2020) The Link between Vitamin D and Covid-19: Distinguishing Facts from Fiction. Journal of Internal Medicine, 289, 131-133.
https://doi.org/10.1111/joim.13158
[31]
Grant, W.B., Lahore, H., McDonnell, S.L., Baggerly, C.A., French, C.B., Aliano, J.L. and Bhattoa, H.P. (2020) Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients, 12, Article No. 988. https://doi.org/10.3390/nu12040988
[32]
Han, J.E., Jones, J.L., Tangpricha, V., et al. (2016) High Dose Vitamin D Administration in Ventilated Intensive Care Unit Patients: A Pilot Double Blind Randomized Controlled Trial. Journal of Clinical & Translational Endocrinology, 4, 59-65.
https://doi.org/10.1016/j.jcte.2016.04.004
[33]
Amrein, K., Schnedl, C., Berghold, A., et al. (2014) Correction of Vitamin D Deficiency in Critically Ill Patients: A Randomized Placebo-Controlled Trial. Clinical Nutrition, 33, S13. https://doi.org/10.1016/S0261-5614(14)50030-1
[34]
Kory, P., Meduri, G.U., Iglesias, J., Varon, J., Cadegiani, F.A. and Marik, P.E. (2022) “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale. Journal of Clinical Medicine Research, 14, 53-79.
https://doi.org/10.14740/jocmr4658
[35]
Yisak, H., Ewunetei, A., Kefale, B., Mamuye, M., Teshome, F., Ambaw, B. and Yideg Yitbarek, G. (2021) Effects of Vitamin D on COVID-19 Infection and Prognosis: A Systematic Review. Risk Management and Healthcare Policy, 14, 31-38.
https://doi.org/10.2147/RMHP.S291584
[36]
Pludowski, P., Holick, M.F., Grant, W.B., Konstantynowicz, J., Mascarenhas, M.R., Haq, A., Povoroznyuk, V., Balatska, N., Barbosa, A.P., Karonova, T., et al. (2018) Vitamin D Supplementation Guidelines. The Journal of Steroid Biochemistry and Molecular Biology, 175, 125-135. https://doi.org/10.1016/j.jsbmb.2017.01.021
[37]
Kimball, S.M. and Holick, M.F. (2020) Official Recommendations for Vitamin D through the Life Stages in Developed Countries. European Journal of Clinical Nutrition, 74, 1514-1518. https://doi.org/10.1038/s41430-020-00706-3
[38]
Ebadi, M. and Montano-Loza, A.J. (2020) Perspective: Improving Vitamin D Status in the Management of COVID-19. European Journal of Clinical Nutrition, 74, 856-859.
https://doi.org/10.1038/s41430-020-0661-0
[39]
Wimalawansa, S.J. (2020) Global Epidemic of Coronavirus—COVID-19: What Can We Do to Minimize Risks. European Journal of Biomedical and Pharmaceutical Sciences, 7, 432-438.
[40]
Charoenngam, N. and Holick, M.F. (2020) Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients, 12, Article No. 2097.
https://doi.org/10.3390/nu12072097
[41]
Charoenngam, N., Shirvani, A. and Holick, M.F. (2021) Vitamin D and Its Potential Benefit for the COVID-19 Pandemic. Endocrine Practice, 27, 484-493.
https://doi.org/10.1016/j.eprac.2021.03.006
[42]
Hovsepian, S., Amini, M., Aminorroaya, A., Amini, P. and Iraj, B. (2011) Prevalence of Vitamin D Deficiency among Adult Population of Isfahan City, Iran. Journal of Health, Population and Nutrition, 29, 149-155.
https://doi.org/10.3329/jhpn.v29i2.7857
[43]
Daniel, D. and Bikle, D.D. (2021) Vitamin D: Production, Metabolism and Mechanisms of Action. In: Feingold, K.R., Anawalt, B., Blackman, M.R., et al., Eds., Endotext, MDText.com, Inc., South Dartmouth (MA).
https://www.ncbi.nlm.nih.gov/books/NBK278935/#
[44]
Ramasamy, I. (2020) Vitamin D Metabolism and Guidelines for Vitamin D Supplementation. The Clinical Biochemist Reviews, 41, 103-126.
[45]
Trang, H.M., Cole, D.E., Rubin, L.A., Pierratos, A., Siu, S. and Vieth, R. (1998) Evidence that Vitamin D3 Increases Serum 25-Hydroxyvitamin D More Efficiently Than Does Vitamin D2. The American Journal of Clinical Nutrition, 68, 854-858.
https://doi.org/10.1093/ajcn/68.4.854
